1. HEADLINES
-=6
 Indian Market
 Indian equity markets were up 0.72%
 Nifty down by 39.85 pts and settle at
5568.00
 Sensex up by 115.24 pts at 18357.80
 Bank Nifty up by 116.20 pts at 11526.30
 Global Market
DAILY EQUITY
 European markets were down with FTSE
NEWSLETTER down by 82.40 closed at 6301 ,CAC
down by 41.78 closed at 3687 and DAX
16TH APRIL 2013
down 84.84 closed at 7659
Dow future was down by 57 closed at
14764.00
 HEADLINES
• Wholesale inflation dips to 5.96% in
March; a 40-month low
• Banks extend gains on hopes of rate cut
on May 3
• ONGC may find more oil in Mumbai's D1
block, shares up 3%
• JSPL hikes steel product prices by Rs
500-Rs 1500
WWW.EPICRESEARCH.CO 09752199966

2.  MARKET ANALYSIS:
 Key benchmark indices trimmed gains in late trade. The barometer index, the S&P BSE Sensex, was
provisionally up 92.07 points or 0.5%, off 89.77 points from day's high and up 190.41 points from the
day's high. Index heavyweight Reliance Industries (RIL) advanced ahead of the company's Q4 results
tomorrow, 16 April 2013. Another index heavyweight and cigarette major ITC gained. The market
breadth, indicating the overall health of the market, was positive.
 Bank stocks edged higher on hopes of interest rate cut from the Reserve Bank of India after latest data
released by the government today, 15 April 2013, showed that inflation dropped sharply in March 2013
over February 2013.
 PSU OMCs rose as crude oil prices declined. Infosys gained in volatile trade on bargain hunting after
Friday's slump triggered by the company issuing tepid revenue guidance at the time of announcing Q4
March 2013 and the year ended 31 March 2013 results. Tata Steel hit 52-week low. Shares of pharma
major Lupin reversed direction after scaling a record high after the company's subsidiary received final
approval from USFDA to market a generic version of Teva Branded Pharm's Seasonique Tablets.
Shares of another pharma firm Wockhardt extended Friday's steep slide in volatile trade.
 ONGC jumped 3.44% and was the top gainer from the Sensex pack. Lower crude oil prices will reduce
under-recovery of state-run oil marketing companies (PSU OMCs) on domestic sale of diesel, LPG and
kerosene at government controlled prices
STOCKS TO WATCH
 FII’s and DII’s  WOCKHARDT
CATEGORY DATE BUY SELL NET  BAJAJ FIN SERV
FII 15-Apr-13 2827.5 3245.87 -418.37  PVR
 SUN PHARMA
DII 15-Apr-13 1072.09 774.91 297.18
SCRIPS IN BAN PERIOD
 NIFTY DAILY PIVOTS  HDIL
PIVOT R4 R3 R2 R1 PP S1 S2 S3 S4
NIFTY 5829 5737 5645 5606 5553 5514 5461 5369 5277
WWW.EPICRESEARCH.CO 09752199966

3. .
 GAINERS AND LOOSERS
EXPERT OPINION
NIFTY
DAILY NIFTY GAINERS
 Nifty looks Bearish
SCRIPS RATE VOL. PR. NET %
 Strategy: Sell on rise
(000) CLOSE CHAN CHANG
GE E  Support: 5500
BPCL 394.80 2636.29 374.35 20.45 5.46  Resistance: 5600
Bank Of BANK NIFTY
677.85 873.09 655.35 22.50 3.43
Baroda
 Bank Nifty looks Bearish
ONGC 319.00 5666.69 308.80 10.20 3.30
 Strategy: Sell on rise
Ultratech
1872.35 238.12 1815.45 56.90 3.13  Support: 11450
Cement
SBI 2146.30 1808.90 2081.80 64.50 3.10  Resistance: 11600
460
 PREVIOUS PERFORMANCE
.0
DAILY NIFTY LOOSERS
TYPE SCRIP B/S RESULT
SCRIPS RATE VOL. PR. NET %
(000) CLOSE CHAN CHAN ANDHRA NOT
CASH S
BANK EXECUTED
GE GE
CASH WOCKHRADT S SL TRIGERRED
Sesa Goa 143.60 1242.14 147.95 -4.35 -2.94
Dr FUTURE AMBUJA B TGT HIT
1852.65 127.10 1903.80 -51.15 -2.69
Reddys Lab
AUROBINDO
FUTURE B TGT HIT
TCS 1472.45 2695.75 1511.75 -39.30 -2.60 PHARMA
Tata
269.00 7759.52 275.15 -6.15 -2.24
Motors
DLF 242.10 7006.22 247.40 -5.30 -2.14
WWW.EPICRESEARCH.CO 09752199966

4. MARKET CALLS
6 CASH
SCRIPS ACTION LEVEL 1ST TARGET 2ND TARGET STOP LOSS
PVR BUY 300.00 302.00 304.00 298.00
WOCKHARDT SELL 1711.00 1701.00 1691.00 1721.00
FUTURE
ST ND
SCRIPS ACTION LEVEL 1 TARGET 2 TARGET STOP LOSS
.
ALLAHBAD BANK BUY 130.00 131.00 132.00 129.00
APOLLO TYRE BUY 84.30 84.80 85.30 83.80
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any
responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on
sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually
tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and
encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on
the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks
recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views
expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of
the information is the acceptance of this disclaimer.
All Rights Reserved. Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any
financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to
buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls
or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious
Legal Actions can be taken.